华芢生物-B(02396)今日盘中大跌8.38%，引发市场关注。该股为今日新上市的生物制药公司，开盘即较发行价38.2港元低开11.52%，盘中跌幅进一步扩大。
消息面上，华芢生物-B的IPO表现不佳是股价下跌的主要原因。尽管其香港公开发售部分获得了791.95倍的超额认购，但投资者对公司的财务健康状况持谨慎态度。招股书显示，公司2024年及2025年前九个月收入为零，净亏损持续扩大至人民币2.12亿元，且完全依赖融资维持运营。此外，其核心产品仍处于临床研发阶段，尚未产生商业化收入，进一步加剧了市场担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.